Biofrontera Pursues Spin-Out IPO Plan

RapidEye/E+ via Getty Images
Quick Take
Biofrontera (BFRI) has filed to raise $25 million in an IPO of its common stock, according to an S-1/A registration statement.
The firm commercializes pharmaceutical products for skin conditions due to too much…

Click here to view the original article.